Welcome to our dedicated page for Cfn Enterprises SEC filings (Ticker: CNFN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cfn Enterprises's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cfn Enterprises's regulatory disclosures and financial reporting.
CFN Enterprises Inc. (CNFN) reported a sharp deterioration in profitability for Q3 2025 despite steady sales. Net revenues for the quarter were $6.6 million, down slightly from $6.8 million a year earlier, but gross profit fell to $1.7 million from $4.4 million as cost of revenue more than doubled. The company swung from net income of $972,900 in Q3 2024 to a net loss of $433,796, or $0.06 per share.
For the first nine months of 2025, revenue nearly doubled to $31.2 million, driven mainly by the Ranco AGP segment’s sales of mitragynine-related products purchased from a related party, but higher product and fulfillment costs cut gross profit to $2.1 million and produced a net loss of $5.2 million, or $0.65 per share. CFN ended September 30, 2025 with $102,324 in cash, total assets of $5.5 million, total liabilities of $28.2 million, a working capital deficit of $24.4 million and an accumulated deficit of $84.4 million, and its auditors highlight substantial doubt about its ability to continue as a going concern.
CFN Enterprises Inc. (CNFN) filed a Form 12b-25 to notify a delay in submitting its Quarterly Report on Form 10-Q for the period ended September 30, 2025. The company states it cannot file on time without unreasonable effort or expense because it is still completing its financial statements, and it expects to file within the 5-day extension allowed by the rules.
Based on preliminary estimates, CFN reports that net income (loss) available to common shareholders was approximately $0.97 million and $(0.92) million for the three and nine months ended September 30, 2024, and it now anticipates net losses of about $0.43 million and $5.2 million for the same 2025 periods. These figures are preliminary, unaudited, and may change when the financial statements are completed.
CFN Enterprises Inc. completed the acquisition of Prestige Worldwide Wine Company, LLC through its wholly owned subsidiary J Street Capital Partners. The deal closed on November 3, 2025, with consideration of 150,000 shares of CFN common stock issued under Section 4(a)(2) of the Securities Act.
The acquired assets include global trademarks, intellectual property, formulations, and Prestige’s distributor network and client base. The seller agreed to a 12‑month lockup from issuance and a 48‑month leak‑out. In connection with closing, J Street entered a one‑year consulting agreement with Wine Trends Marketing, LLC for the winemaking services of industry veteran Thomas Hinde. The board views the Prestige acquisition as a key element of the company’s evolving strategy and is reviewing potential strategic options for subsidiary Ranco, LLC.
FAQ
What is the current stock price of Cfn Enterprises (CNFN)?
What is the market cap of Cfn Enterprises (CNFN)?
